PNC Financial Services Group’s PDS Biotechnology PDSB Stock Holding History

PNC Financial Services Group’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5K	Buy	+11,900	New	+$12.6K	﹤0.01%	4064
2024 Q2	–	Sell	-8	Closed	-$32	–	4881
2024 Q1	$32	Hold	8	–	–	﹤0.01%	4669
2023 Q4	$40	Buy	+8	New	+$40	﹤0.01%	4580
2022 Q1	–	Sell	-1,000	Closed	-$8K	–	4659
2021 Q4	$8K	Buy	+1,000	New	+$10.8K	﹤0.01%	3854
2020 Q3	–	Sell	-300	Closed	-$1K	–	4011
2020 Q2	$1K	Hold	300	–	–	﹤0.01%	3859
2020 Q1	$0	Hold	300	–	–	﹤0.01%	4019
2019 Q4	$1K	Hold	300	–	–	﹤0.01%	3901
2019 Q3	$1K	Hold	300	–	–	﹤0.01%	3934
2019 Q2	$2K	Hold	300	–	–	﹤0.01%	3877
2019 Q1	$2K	Hold	300	–	–	﹤0.01%	3886
2018 Q4	$2K	Hold	300	–	–	﹤0.01%	3870
2018 Q3	$5K	Hold	300	–	–	﹤0.01%	3824
2018 Q2	$6K	Buy	+300	New	+$6.26K	﹤0.01%	3805

Other funds holding PDSB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

MCM

Militia Capital Management Austin, Texas $3.37B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

PNC Financial Services Group's PDSB Position: Q2 2026 in Review

PNC Financial Services Group opened a new position in PDS Biotechnology (PDSB) in Q2 2026: 11,900 shares worth $10.5K. The stake represents ﹤0.01% of the portfolio and ranks #4064 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in PDSB as recently as Q1 2024.

PNC Financial Services Group first reported a position in PDSB in Q2 2018 and has held it in 13 quarters since. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

PNC Financial Services Group held 11,900 shares of PDS Biotechnology worth $10.5K as of Q2 2026.
PDS Biotechnology was a new PNC Financial Services Group position in Q2 2026.
PDS Biotechnology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4064 holding.
PNC Financial Services Group first reported a position in PDS Biotechnology in Q2 2018 and has held it in 13 quarters since.
52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.